Table 10.6a

Immunosuppression Use for Induction, 1993 to 2002

Recipients with Intestine Transplants

	Year of Transplant
	1993	1994	1995	1996	1997	1998	1999	2000	2001	2002
Transplants	34	23	46	45	68	70	73	79	111	107
Tx With Immunosuppression Info	31	23	43	34	66	69	71	78	111	106
No Induction Drugs Recorded	100.0%	82.6%	93.0%	85.3%	92.4%	59.4%	39.4%	30.8%	44.1%	43.4%
Drugs	-	-	0.0%	0.0%	-	-	-	-	-	-
ALG
ATG	-	-	-	2.9%	3.0%	0.0%	-	1.3%	-	0.9%
NRATG/NRATS	-	-	-	-	-	0.0%	-	-	-	-
OKT3	0.0%	17.4%	7.0%	11.8%	4.5%	2.9%	9.9%	5.1%	6.3%	1.9%
Thymoglobulin	-	-	-	-	-	-	4.2%	0.0%	12.6%	31.1%
Zenapax	-	-	-	-	-	36.2%	49.3%	55.1%	23.4%	8.5%
Simulect	0.0%	0.0%	0.0%	0.0%	0.0%	1.4%	1.4%	12.8%	13.5%	14.2%

Source: OPTN/SRTR Data as of August 1, 2003.

(-) = Drug not used anytime during the year.

Induction drugs include any reported antilymphocyte antibodies and antibodies directed against lymphocyte receptors.